| Name | Title | Contact Details |
|---|
Biolux Research Ltd. is a world leader in the development of innovative Light Accelerated™ technology and products for use in orthodontics, implantology, and other dentistry markets.
Orchid Medica mission is to have a knowledgeable staff that delivers sincere care with the highest quality products and services to expedite a safe recovery for the patient. Orchid Medical is a one-stop, fully comprehensive medical service company with a nationwide network of service providers. We offer a broad range of ancillary medical services including DME, Orthotics and Prosthetics, Home Health Care, Diagnostic Imaging and Physical Therapy. Every day we work to accomplish our mission by creating a professional and enthusiastic work environment that promotes continuing education, team building skills, and promotion from within. This atmosphere fosters our “We`ll Take Care of it!” motto by producing happy employees who provide outstanding customer service. From a live person answering every call, to timely turnaround in scheduling appointments, to competitive and fair pricing – we strive to make every experience with Orchid positive, seamless, and professional. You can trust that your patient or injured worker is receiving the best care possible in the hands of Orchid Medical. Contracting directly with medical care facilities and providers, Orchid has developed a comprehensive national network of quality service providers. Our credentialing process is constantly a work in progress- ensuring you are receiving the most experienced providers at the best price. Our exclusive reporting system, OMNI™ (Orchid Medical Network Integration), delivers the precise information you need in the format you want. Specifically designed for claims tracking and management, OMNI™ is versatile, powerful and readily adapts to your business model. Customized reporting and secure, full-time access enables you to effectively analyze data and make the decisions that improve your business performance.
Bosley is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Agility Therapy is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies only target one component of the immunosuppressive TME and a broader, more multi-faceted therapeutic approach is required. We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface is leveraging its deep understanding of TME biology to target factors and cells that suppress patients’ anti-tumor immune response. Our broad attack on the TME has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. We push ourselves to break through across all dimensions of our work. From a discovery perspective, Surface leverages its world-class SAB to identify new targets and takes an aggressive approach towards generating diverse, highly-specific antibodies, which allows our scientists to thoroughly explore the relevant biology. Our antibody discovery approach generates therapeutic-quality antibodies, as well as unique tools to explore the biology of the tumor microenvironment.